Report Overview
A Psychiatric Long-acting Injection (LAI) is a type of medication used in the treatment of various psychiatric disorders, such as schizophrenia, bipolar disorder, and major depressive disorder. These injections are designed to provide a consistent and controlled release of the active pharmaceutical ingredient over an extended period, typically ranging from two to four weeks. The primary advantage of LAIs is their ability to maintain therapeutic drug levels in the bloodstream, reducing the risk of non-adherence and relapse, which is a common issue with oral medications. Psychiatric LAIs are administered by healthcare professionals and are an important tool in the management of chronic mental health conditions, particularly for patients who struggle with medication compliance or require a more stable and predictable drug delivery system.
In 2024, the global Psychiatric Long-acting Injection market is projected to reach approximately USD xx Million, with expectations to grow at a compound annual growth rate (CAGR) of around xx between 2024 and 2033.
This report provides a deep insight into the global Psychiatric Long-acting Injection market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Psychiatric Long-acting Injection Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Psychiatric Long-acting Injection market in any manner.
Global Psychiatric Long-acting Injection Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Oakwood Labs
Teva
MedinCell
Janssen
Otsuka America Pharmaceutical
Inc.
Lundbeck
Eli Lilly
Alkermes
Par Pharmaceutical
AbbVie
Luye Pharmaceutical
Market Segmentation (by Type)
Aripiprazole Long-acting Injection
Haloperidol Long-acting Injection
Paliperidone Long-acting Injection
Risperidone Long-acting Injection
Olanzapine Long-acting Injection
Others
Market Segmentation (by Application)
Schizophrenia
Bipolar Disorder
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Psychiatric Long-acting Injection Market
Overview of the regional outlook of the Psychiatric Long-acting Injection Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Psychiatric Long-acting Injection Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market\'s competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter\'s five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Psychiatric Long-acting Injection, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Psychiatric Long-acting Injection
1.2 Key Market Segments
1.2.1 Psychiatric Long-acting Injection Segment by Type
1.2.2 Psychiatric Long-acting Injection Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Psychiatric Long-acting Injection Market Overview
2.1 Global Market Overview
2.1.1 Global Psychiatric Long-acting Injection Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Psychiatric Long-acting Injection Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Psychiatric Long-acting Injection Market Competitive Landscape
3.1 Company Assessment Quadrant
3.2 Global Psychiatric Long-acting Injection Product Life Cycle
3.3 Global Psychiatric Long-acting Injection Sales by Manufacturers (2020-2025)
3.4 Global Psychiatric Long-acting Injection Revenue Market Share by Manufacturers (2020-2025)
3.5 Psychiatric Long-acting Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Psychiatric Long-acting Injection Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 Psychiatric Long-acting Injection Market Competitive Situation and Trends
3.8.1 Psychiatric Long-acting Injection Market Concentration Rate
3.8.2 Global 5 and 10 Largest Psychiatric Long-acting Injection Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 Psychiatric Long-acting Injection Industry Chain Analysis
4.1 Psychiatric Long-acting Injection Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Psychiatric Long-acting Injection Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Psychiatric Long-acting Injection Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy – April 2025
5.6.3 Global Trade Frictions and Their Impacts to Psychiatric Long-acting Injection Market
5.7 ESG Ratings of Leading Companies
6 Psychiatric Long-acting Injection Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Psychiatric Long-acting Injection Sales Market Share by Type (2020-2025)
6.3 Global Psychiatric Long-acting Injection Market Size Market Share by Type (2020-2025)
6.4 Global Psychiatric Long-acting Injection Price by Type (2020-2025)
7 Psychiatric Long-acting Injection Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Psychiatric Long-acting Injection Market Sales by Application (2020-2025)
7.3 Global Psychiatric Long-acting Injection Market Size (M USD) by Application (2020-2025)
7.4 Global Psychiatric Long-acting Injection Sales Growth Rate by Application (2020-2025)
8 Psychiatric Long-acting Injection Market Sales by Region
8.1 Global Psychiatric Long-acting Injection Sales by Region
8.1.1 Global Psychiatric Long-acting Injection Sales by Region
8.1.2 Global Psychiatric Long-acting Injection Sales Market Share by Region
8.2 Global Psychiatric Long-acting Injection Market Size by Region
8.2.1 Global Psychiatric Long-acting Injection Market Size by Region
8.2.2 Global Psychiatric Long-acting Injection Market Size Market Share by Region
8.3 North America
8.3.1 North America Psychiatric Long-acting Injection Sales by Country
8.3.2 North America Psychiatric Long-acting Injection Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Psychiatric Long-acting Injection Sales by Country
8.4.2 Europe Psychiatric Long-acting Injection Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Psychiatric Long-acting Injection Sales by Region
8.5.2 Asia Pacific Psychiatric Long-acting Injection Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Psychiatric Long-acting Injection Sales by Country
8.6.2 South America Psychiatric Long-acting Injection Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Psychiatric Long-acting Injection Sales by Region
8.7.2 Middle East and Africa Psychiatric Long-acting Injection Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 Psychiatric Long-acting Injection Market Production by Region
9.1 Global Production of Psychiatric Long-acting Injection by Region(2020-2025)
9.2 Global Psychiatric Long-acting Injection Revenue Market Share by Region (2020-2025)
9.3 Global Psychiatric Long-acting Injection Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Psychiatric Long-acting Injection Production
9.4.1 North America Psychiatric Long-acting Injection Production Growth Rate (2020-2025)
9.4.2 North America Psychiatric Long-acting Injection Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Psychiatric Long-acting Injection Production
9.5.1 Europe Psychiatric Long-acting Injection Production Growth Rate (2020-2025)
9.5.2 Europe Psychiatric Long-acting Injection Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Psychiatric Long-acting Injection Production (2020-2025)
9.6.1 Japan Psychiatric Long-acting Injection Production Growth Rate (2020-2025)
9.6.2 Japan Psychiatric Long-acting Injection Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Psychiatric Long-acting Injection Production (2020-2025)
9.7.1 China Psychiatric Long-acting Injection Production Growth Rate (2020-2025)
9.7.2 China Psychiatric Long-acting Injection Production, Revenue, Price and Gross Margin (2020-2025)
10 Key Companies Profile
10.1 Oakwood Labs
10.1.1 Oakwood Labs Basic Information
10.1.2 Oakwood Labs Psychiatric Long-acting Injection Product Overview
10.1.3 Oakwood Labs Psychiatric Long-acting Injection Product Market Performance
10.1.4 Oakwood Labs Business Overview
10.1.5 Oakwood Labs SWOT Analysis
10.1.6 Oakwood Labs Recent Developments
10.2 Teva
10.2.1 Teva Basic Information
10.2.2 Teva Psychiatric Long-acting Injection Product Overview
10.2.3 Teva Psychiatric Long-acting Injection Product Market Performance
10.2.4 Teva Business Overview
10.2.5 Teva SWOT Analysis
10.2.6 Teva Recent Developments
10.3 MedinCell
10.3.1 MedinCell Basic Information
10.3.2 MedinCell Psychiatric Long-acting Injection Product Overview
10.3.3 MedinCell Psychiatric Long-acting Injection Product Market Performance
10.3.4 MedinCell Business Overview
10.3.5 MedinCell SWOT Analysis
10.3.6 MedinCell Recent Developments
10.4 Janssen
10.4.1 Janssen Basic Information
10.4.2 Janssen Psychiatric Long-acting Injection Product Overview
10.4.3 Janssen Psychiatric Long-acting Injection Product Market Performance
10.4.4 Janssen Business Overview
10.4.5 Janssen Recent Developments
10.5 Otsuka America Pharmaceutical
10.5.1 Otsuka America Pharmaceutical Basic Information
10.5.2 Otsuka America Pharmaceutical Psychiatric Long-acting Injection Product Overview
10.5.3 Otsuka America Pharmaceutical Psychiatric Long-acting Injection Product Market Performance
10.5.4 Otsuka America Pharmaceutical Business Overview
10.5.5 Otsuka America Pharmaceutical Recent Developments
10.6 Inc.
10.6.1 Inc. Basic Information
10.6.2 Inc. Psychiatric Long-acting Injection Product Overview
10.6.3 Inc. Psychiatric Long-acting Injection Product Market Performance
10.6.4 Inc. Business Overview
10.6.5 Inc. Recent Developments
10.7 Lundbeck
10.7.1 Lundbeck Basic Information
10.7.2 Lundbeck Psychiatric Long-acting Injection Product Overview
10.7.3 Lundbeck Psychiatric Long-acting Injection Product Market Performance
10.7.4 Lundbeck Business Overview
10.7.5 Lundbeck Recent Developments
10.8 Eli Lilly
10.8.1 Eli Lilly Basic Information
10.8.2 Eli Lilly Psychiatric Long-acting Injection Product Overview
10.8.3 Eli Lilly Psychiatric Long-acting Injection Product Market Performance
10.8.4 Eli Lilly Business Overview
10.8.5 Eli Lilly Recent Developments
10.9 Alkermes
10.9.1 Alkermes Basic Information
10.9.2 Alkermes Psychiatric Long-acting Injection Product Overview
10.9.3 Alkermes Psychiatric Long-acting Injection Product Market Performance
10.9.4 Alkermes Business Overview
10.9.5 Alkermes Recent Developments
10.10 Par Pharmaceutical
10.10.1 Par Pharmaceutical Basic Information
10.10.2 Par Pharmaceutical Psychiatric Long-acting Injection Product Overview
10.10.3 Par Pharmaceutical Psychiatric Long-acting Injection Product Market Performance
10.10.4 Par Pharmaceutical Business Overview
10.10.5 Par Pharmaceutical Recent Developments
10.11 AbbVie
10.11.1 AbbVie Basic Information
10.11.2 AbbVie Psychiatric Long-acting Injection Product Overview
10.11.3 AbbVie Psychiatric Long-acting Injection Product Market Performance
10.11.4 AbbVie Business Overview
10.11.5 AbbVie Recent Developments
10.12 Luye Pharmaceutical
10.12.1 Luye Pharmaceutical Basic Information
10.12.2 Luye Pharmaceutical Psychiatric Long-acting Injection Product Overview
10.12.3 Luye Pharmaceutical Psychiatric Long-acting Injection Product Market Performance
10.12.4 Luye Pharmaceutical Business Overview
10.12.5 Luye Pharmaceutical Recent Developments
11 Psychiatric Long-acting Injection Market Forecast by Region
11.1 Global Psychiatric Long-acting Injection Market Size Forecast
11.2 Global Psychiatric Long-acting Injection Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Psychiatric Long-acting Injection Market Size Forecast by Country
11.2.3 Asia Pacific Psychiatric Long-acting Injection Market Size Forecast by Region
11.2.4 South America Psychiatric Long-acting Injection Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Psychiatric Long-acting Injection by Country
12 Forecast Market by Type and by Application (2026-2033)
12.1 Global Psychiatric Long-acting Injection Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Psychiatric Long-acting Injection by Type (2026-2033)
12.1.2 Global Psychiatric Long-acting Injection Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Psychiatric Long-acting Injection by Type (2026-2033)
12.2 Global Psychiatric Long-acting Injection Market Forecast by Application (2026-2033)
12.2.1 Global Psychiatric Long-acting Injection Sales (K Units) Forecast by Application
12.2.2 Global Psychiatric Long-acting Injection Market Size (M USD) Forecast by Application (2026-2033)
13 Conclusion and Key Findings
